A group program to improve prenatal care for Marshallese women
Official title: Exploring the Feasibility of a Group Prenatal Program, Kommour Prenatal, to Reduce Maternal and Infant Health Disparities among Marshallese Women
Funded at Arkansas Children's Hospital Res Inst · NIH-11170307 · Data updated 2026-11-12
This study is looking at a special group prenatal program called Kommour Prenatal, which helps Marshallese women during pregnancy by offering support and education that fits their culture, with the goal of improving health for both moms and babies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arkansas Children's Hospital Res Inst NIH-funded |
| Lab location | 1 site (Little Rock, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $99,007 |
| NIH project number | 5P20GM109096-09 |
| Project ID | NIH-11170307 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are pregnant Marshallese women living in Arkansas.
✕Less likely to help
Patients who are not of Marshallese descent or who are not currently pregnant may not receive benefit from this research.
What this research studies
This research investigates a group prenatal program called Kommour Prenatal, specifically designed to address and reduce health disparities faced by Marshallese women during pregnancy. The program aims to provide culturally tailored interventions that focus on improving maternal and infant health outcomes. By implementing this program, the research will assess its feasibility and effectiveness in a community setting, with a focus on addressing issues such as cesarean deliveries and childhood obesity. Participants will engage in group sessions that offer support, education, and resources tailored to their cultural needs.
Why it matters
Potential benefit: If successful, this research could lead to improved maternal and infant health outcomes for Marshallese women and their children.
How similar studies have gone: Similar culturally tailored interventions have shown promise in improving health outcomes in diverse populations, suggesting potential success for this approach.
Where this research is happening
-
Arkansas Children's Hospital Res Inst
Little Rock, United States Active
Researchers
- Principal investigator: Ayers, Britni Lee — Arkansas Children's Hospital Res Inst
- Study coordinator: Ayers, Britni Lee
Related research
Other NIH-funded projects on the same topics.
-
Shorter antifungal treatment for kids with candidemia
A multi-center pediatric trial tests whether a shorter, 7 extra days of antifungal therapy after an initial 7 days is just as good as the standard 14-day approach for kids with candidemia who are improving on echinocandin therapy.
-
Short Course vs Standard Course Antifungal Therapy for Pediatric Candidemia
This study tests whether a shorter 7-day total antifungal treatment after an initial 7 days of echinocandin therapy is as effective as the usual 14-day course for children with candidemia.
-
Shorter antifungal treatment for kids with candidemia
A multi-center study tests whether kids with candidemia can finish treatment earlier after an initial week of antifungal therapy than the standard two weeks total.
-
Shorter antifungal treatment for kids with candidemia
This study tests whether children with candidemia can finish treatment after 7 days of an echinocandin if they are improving, instead of completing a full 14 days.
-
Shorter antifungal course for kids with candidemia
A multi-center study tests whether 7 extra days of antifungal therapy after an initial week of treatment can be shortened safely for children with candidemia.
-
Shortened antifungal treatment for kids with candidemia
A pediatric multicenter trial will test whether stopping antifungal therapy after 7 more days, following an initial 7 days of treatment, isas safe as continuing for 14 days.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.